Presentation is loading. Please wait.

Presentation is loading. Please wait.

4155 primary hepatocellular carcinoma with known diagnosis month/year

Published byIrene Parker Modified over 6 years ago

Similar presentations

Presentation on theme: "4155 primary hepatocellular carcinoma with known diagnosis month/year"— Presentation transcript:

1 6825 liver cancer cases in elderly aged >=65 years reported to SEER in 2007-2009
4155 primary hepatocellular carcinoma with known diagnosis month/year 2015 with AJCC stage I/II hepatocellular carcinoma 1768 cases with continual enrollment in Medicare Parts A and B 2670 non primary cases, non carcinoma, diagnosed at autopsy, or missing diagnosis date 2140 with stage III/IV hepatocellular carcinoma or unknown stage 247 not continually enrolled in Medicare Parts A, B 1036 cases with continual enrollment in Medicare Part D 732 not continually enrolled in Medicare Part D Supplementary Figure S1. Selection of Medicare patients diagnosed with hepatocellular carcinoma for investigation of the association of statin use and survival

Download ppt "4155 primary hepatocellular carcinoma with known diagnosis month/year"

Similar presentations

FEMALE BREAST CANCER 2009-2013 JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.

FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.
THYROID CANCER 2008 - 2012 JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.
PROSTATE CANCER 2008 - 2012 JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.
MELANOMA 2009-2013 JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.
LUNG CANCER 2003-2006. Johns Hopkins Hospital Lung Cancer, Non-Small Cell 2003-2006, All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.
PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.

PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.
THYROID CANCER 2009-2013 JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.
GASTRIC CANCER JHH 2002 - 2006. Johns Hopkins Hospital Gastric Cancer 2002-2006, All Cases n=317 Analytic - Initially Diagnosed and/or received all or.

GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.
ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.

ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.
The Burden of Cancer in Connecticut Lou Gonsalves Connecticut Tumor Registry

The Burden of Cancer in Connecticut Lou Gonsalves Connecticut Tumor Registry
HEAD/NECK CARCINOMA 2002-2006 Johns Hopkins Hospital.

HEAD/NECK CARCINOMA Johns Hopkins Hospital.
JHH Prostate Cancer 1999-2004. Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.

JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.
1 Yize R. Wang, MD, PhD, John R. Cangemi, MD, Edward V. Loftus Jr, MD and Michael F. Picco, MD, PhD Am J Gastroenterol 2013;108:444–449 F1 김혁 / Prof. 김효종.

1 Yize R. Wang, MD, PhD, John R. Cangemi, MD, Edward V. Loftus Jr, MD and Michael F. Picco, MD, PhD Am J Gastroenterol 2013;108:444–449 F1 김혁 / Prof. 김효종.
Date of download: 6/25/2016 From: Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic.

Date of download: 6/25/2016 From: Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic.
Supplementary Figure 1. Importance of first neighbours in breast cancer, hepatocellular carcinoma and non-small cell lung cancer in the SignaLink network.

Supplementary Figure 1. Importance of first neighbours in breast cancer, hepatocellular carcinoma and non-small cell lung cancer in the SignaLink network.
NON-SMALL CELL LUNG CANCER

NON-SMALL CELL LUNG CANCER
A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.

A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
Ovarian Cancer (C56): 2002-2006 Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation provided.

Ovarian Cancer (C56): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation provided.
JOHNS HOPKINS HOSPITAL CANCER REGISTRY

JOHNS HOPKINS HOSPITAL CANCER REGISTRY
Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma  Chi-Fu Jeffrey Yang, MD, Hanghang Wang, MD, PhD, Arvind.

Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma  Chi-Fu Jeffrey Yang, MD, Hanghang Wang, MD, PhD, Arvind.

Similar presentations

Ads by Google